pyrimethamine has been researched along with Complications, Infectious Pregnancy in 169 studies
Maloprim: contains above 2 cpds
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated whether adding community scheduled malaria screening and treatment (CSST) with artemether-lumefantrine by community health workers (CHWs) to standard intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) would improve maternal and infant health." | 9.30 | Community-based Malaria Screening and Treatment for Pregnant Women Receiving Standard Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: A Multicenter (The Gambia, Burkina Faso, and Benin) Cluster-randomized Controlled Trial. ( , 2019) |
| "This was a randomized, open-label trial in 36 French centers, comparing pyrimethamine (50 mg qd) + sulfadiazine (1 g tid) with folinic acid vs spiramycin (1 g tid) following toxoplasmosis seroconversion." | 9.27 | Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial. ( Berrebi, A; Biquard, F; Bory, JP; Cordier, AG; d'Ercole, C; Houfflin-Debarge, V; Jouannic, JM; Kieffer, F; Laurichesse-Delmas, H; Le Bouar, G; Mandelbrot, L; Mesnard, L; Perrotin, F; Sitta, R; Thiébaut, R; Ville, Y; Villena, I; Winer, N, 2018) |
| "In 2003, Mali introduced intermittent preventive therapy in pregnancy (ITPp) with sulfadoxine-pyrimethamine (SP) for the control of malaria in pregnancy, consisting of 2 doses of SP given in the 2nd and 3rd trimester." | 9.15 | Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial. ( Bougoudogo, F; Coulibaly, S; Danis, M; Dara, A; Diakite, OS; Diallo, M; Djimde, A; Doumbo, OK; Doumbo, S; Doumtabé, D; Guindo, O; Karim, DM; Kayentao, K; Maiga, OM; Ongoiba, A; Ter Kuile, FO; Traoré, B; Traoré, BT; Traoré, M; Traoré, MS, 2011) |
| "The World Health Organization advocates 2-3 doses of sulfadoxine-pyrimethamine (SP) for intermittent preventive treatment of malaria (SP IPTp)." | 9.12 | Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women. ( Chalwe, V; Champo, D; Chilengi, R; Gill, CJ; Hamer, DH; Macleod, WB; Mukwamataba, D; Mwanakasale, V; Mwananyanda, L; Thea, DM, 2007) |
| "The World Health Organization recommends intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine for malaria for all women who live in moderate to high malaria transmission areas in Africa." | 8.98 | Mefloquine for preventing malaria in pregnant women. ( Aponte, JJ; González, R; Menéndez, C; Piqueras, M; Pons-Duran, C; Ter Kuile, FO, 2018) |
| "Intermittent preventive therapy with sulfadoxine-pyrimethamine to control malaria during pregnancy is used in 37 countries in sub-Saharan Africa, and 31 of those countries use the standard 2-dose regimen." | 8.89 | Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. ( Ashorn, P; Doumbo, OK; Garner, P; Kayentao, K; Luntamo, M; MacArthur, JR; Mulokozi, A; Naidoo, I; Roper, C; ter Kuile, FO; van Eijk, AM, 2013) |
| "The antifolate sulphadoxine-pyrimethamine (SP) has been used in the intermittent prevention of malaria in pregnancy (IPTp)." | 8.88 | Combination of probenecid-sulphadoxine-pyrimethamine for intermittent preventive treatment in pregnancy. ( Gutman, J; Kachur, SP; Mutabingwa, T; Nzila, A; Slutsker, L, 2012) |
| "Intermittent preventive treatment of malaria in pregnancy with 3+ doses of sulfadoxine-pyrimethamine (IPTp-SP) reduces maternal mortality and stillbirths in malaria endemic areas." | 7.83 | Scaling-up the use of sulfadoxine-pyrimethamine for the preventive treatment of malaria in pregnancy: results and lessons on scalability, costs and programme impact from three local government areas in Sokoto State, Nigeria. ( Abdul-Azeez, J; Abegunde, D; Austin, AM; Beal, K; Fapohunda, B; Ganiyu, H; Ibrahim, M; Mohammed, Z; Nanbol, Z; Orobaton, N, 2016) |
| "Owing to increasing sulfadoxine-pyrimethamine (SP) resistance in sub-Saharan Africa, monitoring the effectiveness of intermittent preventive therapy in pregnancy (IPTp) with SP is crucial." | 7.83 | Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness of Intermittent Preventive Therapy for Malaria in Pregnancy at Clearing Infections and Preventing Low Birth Weight. ( Ades, V; Arinaitwe, E; Chaluluka, E; Coulibaly, SO; Desai, M; Doumbo, O; Edgar, D; Gutman, J; Kalilani, L; Kamuliwo, M; Kayentao, K; Khairallah, C; Mace, KE; Magnussen, P; Mathanga, DP; Meshnick, S; Otieno, K; Ouma, P; Shi, YP; Skarbinski, J; Taylor, SM; Ter Kuile, FO; Wiegand, RE, 2016) |
| "Sulfadoxine/pyrimethamine did not reduce colonization rates when used as the IPTp drug during pregnancy." | 7.81 | Evaluation of intermittent preventive treatment of malaria against group B Streptococcus colonization in pregnant women: a nested analysis of a randomized controlled clinical trial of sulfadoxine/pyrimethamine versus mefloquine. ( Adegnika, AA; Agnandji, ST; Akerey-Diop, D; Basra, A; Bélard, S; Capan-Melser, M; González, R; Groger, M; Kremsner, PG; Lötsch, F; Mackanga, JR; Matsiegui, PB; Menendez, C; Mombo Ngoma, G; Ramharter, M; Rehman, K; Schipulle, U; Schwing, J; Würbel, H; Zoleko-Manego, R, 2015) |
| "The World Health Organization (WHO) recommends for sub-Saharan Africa a package of prompt and effective case-management combined with the delivery of insecticide-treated nets (ITN) and intermittent preventive treatment during pregnancy (IPTp) with sulphadoxine-pyrimethamine (SP) through the national antenatal care (ANC) programs." | 7.80 | Coverage and efficacy of intermittent preventive treatment with sulphadoxine pyrimethamine against malaria in pregnancy in Côte d'Ivoire five years after its implementation. ( Ako, BA; Bassinka, I; Beourou, S; Bokossa, EM; Coulibaly, B; Coulibaly, MA; Esmel, B; Gba, B; Gbessi, EA; Koffi, D; Kone, PL; N' Guessan, LT; Nogbou, M; Soumahoro, A; Swa, T; Toure, OA, 2014) |
| "Intermittent preventive treatment of malaria in pregnancy (IPTp) with sulphadoxine-pyrimethamine (SP) decreases adverse effects of malaria during pregnancy." | 7.80 | Efficacy of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy, Mansa, Zambia. ( Chalwe, V; Craig, AS; Filler, SJ; Kamuliwo, M; Katalenich, BL; Mace, KE; Meshnick, SR; Nambozi, M; Tan, KR; Taylor, SM; Wiegand, RE, 2014) |
| "Despite widespread parasite resistance to sulphadoxine-pyrimethamine (SP) its use for intermittent preventative treatment during pregnancy remains the policy in Benin and throughout most of sub-Saharan Africa." | 7.79 | High rates of parasite recrudescence following intermittent preventive treatment with sulphadoxine-pyrimethamine during pregnancy in Benin. ( Alifrangis, M; De Tove, YS; Deloron, P; Doritchamou, J; Luty, AJ; Massougbodji, A; Moussiliou, A; Ndam, NT, 2013) |
| "Effectiveness of cotrimoxazole (CTX) compared with sulfadoxine-pyrimethamine (SP) intermittent-preventive-therapy (IPTp) for malaria in HIV-infected pregnant women is unknown." | 7.77 | Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi. ( Fitzgerald, M; Kapito-Tembo, A; Meshnick, SR; Mwapasa, V; Phiri, K; van Hensbroek, MB, 2011) |
| "In this study, the intrinsic anti-bacterial activity of mefloquine and azithromycin was assessed in comparison to sulphadoxine-pyrimethamine against bacterial pathogens with clinical importance in pregnancy in a standard microdilution assay." | 7.76 | Anti-bacterial activity of intermittent preventive treatment of malaria in pregnancy: comparative in vitro study of sulphadoxine-pyrimethamine, mefloquine, and azithromycin. ( Capan, M; Makristathis, A; Mombo-Ngoma, G; Ramharter, M, 2010) |
| "To monitor the effectiveness of intermittent preventive treatment (IPT) with sulphadoxine-pyrimethamine (SP) for the control of malaria in pregnancy at delivery in the Provincial Hospital in Kisumu, Kenya, and to assess the effect of IPT in participants in a cohort study." | 7.72 | Effectiveness of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in western Kenya: a hospital-based study. ( Ayisi, JG; Kager, PA; Misore, AO; Nahlen, BL; Odondi, JO; Otieno, JA; Rosen, DH; Steketee, RW; ter Kuile, FO; van Eijk, AM, 2004) |
| "Pregnancy is also associated with the risk of neural tube defects (NTDs), especially in women with low folate status, and folic acid supplementation is recommended in pregnancy to lower the risk of NTDs." | 6.50 | Impact of folate supplementation on the efficacy of sulfadoxine/pyrimethamine in preventing malaria in pregnancy: the potential of 5-methyl-tetrahydrofolate. ( Molloy, AM; Nzila, A; Okombo, J, 2014) |
| "Malaria in pregnancy is a major health problem that can cause maternal anaemia, stillbirth, spontaneous abortion, low birth weight and intra-uterine stunting." | 5.38 | Validity of self-reported use of sulphadoxine-pyrimethamine intermittent presumptive treatment during pregnancy (IPTp): a cross-sectional study. ( Kironde, F; Mirembe, F; Namusoke, F; Ntale, M; Wahlgren, M, 2012) |
| "We investigated whether adding community scheduled malaria screening and treatment (CSST) with artemether-lumefantrine by community health workers (CHWs) to standard intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) would improve maternal and infant health." | 5.30 | Community-based Malaria Screening and Treatment for Pregnant Women Receiving Standard Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: A Multicenter (The Gambia, Burkina Faso, and Benin) Cluster-randomized Controlled Trial. ( , 2019) |
| "Intermittent preventive treatment in pregnancy (IPTp) with azithromycin and monthly sulfadoxine-pyrimethamine increased the mean child weight, mid-upper arm and head circumference at four weeks of age in a rural low-income setting." | 5.30 | The impact of maternal antenatal treatment with two doses of azithromycin and monthly sulphadoxine-pyrimethamine on child weight, mid-upper arm circumference and head circumference: A randomized controlled trial. ( Ashorn, P; Ashorn, U; Cheung, YB; Hallamaa, L; Kulmala, T; Luntamo, M; Mangani, C, 2019) |
| "We enrolled 1320 pregnant Malawian women in a randomized trial and treated them for malaria and other infections with either 2 doses of sulfadoxine-pyrimethamine (SP) (control), monthly SP, or monthly sulfadoxine-pyrimethamine and 2 doses of azithromycin (AZI-SP)." | 5.27 | Child Health Outcomes After Presumptive Infection Treatment in Pregnant Women: A Randomized Trial. ( Ashorn, P; Ashorn, U; Cheung, YB; Gladstone, M; Hallamaa, L; Kulmala, T; Luntamo, M; Maleta, K; Mangani, C, 2018) |
| "This was a randomized, open-label trial in 36 French centers, comparing pyrimethamine (50 mg qd) + sulfadiazine (1 g tid) with folinic acid vs spiramycin (1 g tid) following toxoplasmosis seroconversion." | 5.27 | Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial. ( Berrebi, A; Biquard, F; Bory, JP; Cordier, AG; d'Ercole, C; Houfflin-Debarge, V; Jouannic, JM; Kieffer, F; Laurichesse-Delmas, H; Le Bouar, G; Mandelbrot, L; Mesnard, L; Perrotin, F; Sitta, R; Thiébaut, R; Ville, Y; Villena, I; Winer, N, 2018) |
| "In 2003, Mali introduced intermittent preventive therapy in pregnancy (ITPp) with sulfadoxine-pyrimethamine (SP) for the control of malaria in pregnancy, consisting of 2 doses of SP given in the 2nd and 3rd trimester." | 5.15 | Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial. ( Bougoudogo, F; Coulibaly, S; Danis, M; Dara, A; Diakite, OS; Diallo, M; Djimde, A; Doumbo, OK; Doumbo, S; Doumtabé, D; Guindo, O; Karim, DM; Kayentao, K; Maiga, OM; Ongoiba, A; Ter Kuile, FO; Traoré, B; Traoré, BT; Traoré, M; Traoré, MS, 2011) |
| "Factors involved in the development of resistance to sulphadoxine-pyrimethamine (SP) by Plasmodium falciparum, particularly in the context of intermittent preventive treatment during pregnancy (IPTp), are not well known." | 5.15 | HIV and placental infection modulate the appearance of drug-resistant Plasmodium falciparum in pregnant women who receive intermittent preventive treatment. ( Alonso, PL; Bardají, A; Cisteró, P; Dobaño, C; Mandomando, I; Mayor, A; Menéndez, C; Nhabomba, A; Sanz, S; Scahill, MD; Serra-Casas, E; Sigauque, B, 2011) |
| "The weekly chemoprophylaxis of malaria during pregnancy with chloroquine (CQ) has become problematic with the increasing resistance of Plasmodium falciparum to this drug." | 5.14 | Placental malaria and low birth weight in pregnant women living in a rural area of Burkina Faso following the use of three preventive treatment regimens. ( Bougouma, EC; Diarra, A; Konaté, AT; Nébié, I; Ouedraogo, A; Sirima, SB; Tiono, AB, 2009) |
| "Intermittent preventive treatment with three doses of sulfadoxine-pyrimethamine is a more effective strategy to prevent maternal anemia during pregnancy in Burkina Faso." | 5.13 | [Comparative impact of three malaria preventive regimens during pregnancy on maternal anemia due to malaria in Burkina Faso]. ( Bougouma, EC; Diarra, A; Konaté, AT; Nébié, I; Ouédraogo, A; Sirima, SB; Tiono, AB, 2008) |
| "Intermittent preventive treatment during pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) decreases placental malaria parasitemia and associated maternal anemia, premature delivery, and low birth weight." | 5.12 | Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi. ( Filler, SJ; Hamel, M; Kazembe, P; Macheso, A; Newman, RD; Parise, ME; Steketee, RW; Thigpen, M, 2006) |
| "The World Health Organization advocates 2-3 doses of sulfadoxine-pyrimethamine (SP) for intermittent preventive treatment of malaria (SP IPTp)." | 5.12 | Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women. ( Chalwe, V; Champo, D; Chilengi, R; Gill, CJ; Hamer, DH; Macleod, WB; Mukwamataba, D; Mwanakasale, V; Mwananyanda, L; Thea, DM, 2007) |
| " The purpose was to compare the efficacy of two regimens using chloroquine (CQ) or sulfadoxine-pyrimethamine (SP) during pregnancy and delivery in a village located in an endemic area of Mali." | 5.12 | [Randomized clinical trial of two malaria prophylaxis regimens for pregnant women in Faladie, Mali]. ( Dabo, CA; Diallo, M; Diarra, MA; Doumbo, O; Kayentao, K; Ongoiba, A; Sangho, H; Saye, R; Yattara, O, 2007) |
| "New studies on the suppressive and curative effects of the anti-malarial drug pyrimethamine in pregnant women from Ilorin, Nigeria showed both ineffective prophylaxis and suppression, and parasite resistance." | 5.06 | Lack of efficacy of pyrimethamine prophylaxis in pregnant Nigerian women. ( Adetoro, O; Akintunde, A; Alakija, T; Breman, JG; Edungbola, LD; Nahlen, BL; Nguyen-Dinh, P; Ogunbode, O, 1989) |
| "The World Health Organization recommends intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine for malaria for all women who live in moderate to high malaria transmission areas in Africa." | 4.98 | Mefloquine for preventing malaria in pregnant women. ( Aponte, JJ; González, R; Menéndez, C; Piqueras, M; Pons-Duran, C; Ter Kuile, FO, 2018) |
| " Chemopreventive strategies have been increasingly deployed in Africa, notably intermittent sulfadoxine-pyrimethamine treatment in pregnancy, and monthly amodiaquine-sulfadoxine-pyrimethamine during the rainy season months in children aged between 3 months and 5 years across the sub-Sahel." | 4.90 | Malaria. ( Dondorp, AM; Faiz, MA; Hien, TT; Mokuolu, OA; Pukrittayakamee, S; White, NJ, 2014) |
| "Intermittent preventive therapy with sulfadoxine-pyrimethamine to control malaria during pregnancy is used in 37 countries in sub-Saharan Africa, and 31 of those countries use the standard 2-dose regimen." | 4.89 | Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. ( Ashorn, P; Doumbo, OK; Garner, P; Kayentao, K; Luntamo, M; MacArthur, JR; Mulokozi, A; Naidoo, I; Roper, C; ter Kuile, FO; van Eijk, AM, 2013) |
| "The antifolate sulphadoxine-pyrimethamine (SP) has been used in the intermittent prevention of malaria in pregnancy (IPTp)." | 4.88 | Combination of probenecid-sulphadoxine-pyrimethamine for intermittent preventive treatment in pregnancy. ( Gutman, J; Kachur, SP; Mutabingwa, T; Nzila, A; Slutsker, L, 2012) |
| " Interviews focused on perception of purpose of ANC pharmaceuticals (particularly iron supplements, sulfadoxine-pyrimethamine as intermittent prevention of malaria and antiretroviral therapy for HIV), beliefs regarding efficacy and risk, and understanding of dosage and regimen." | 3.96 | "They Merely Prescribe and I Merely Swallow": Perceptions of Antenatal Pharmaceuticals and Nutritional Supplements Among Pregnant Women in Bamako, Mali. ( Doumbia, SO; Hurley, EA; Searle, AR; Winch, PJ, 2020) |
| " Optimum use of Intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine (IPTp-SP) and immunization against tetanus among pregnant women during antenatal care (ANC) visits are recommended strategies to prevent these issues." | 3.91 | Antenatal visits are positively associated with uptake of tetanus toxoid and intermittent preventive treatment in pregnancy in Ivory Coast. ( Bishwajit, G; Buh, A; Kota, K; Yaya, S, 2019) |
| "Intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP), provided as part of routine antenatal care (ANC), is one of three malaria-in-pregnancy prevention and control mechanisms recommended by the World Health Organization (WHO)." | 3.83 | Assessing supply-side barriers to uptake of intermittent preventive treatment for malaria in pregnancy: a qualitative study and document and record review in two regions of Uganda. ( Graham, K; Gudoi, SS; King, R; Meier, J; Mufubenga, P; Rassi, C, 2016) |
| "The Uganda National Malaria Control Programme recommends the use of intermittent preventive therapy in pregnancy with sulfadoxine/pyrimethamine (SP) to prevent malaria, however, there is overwhelming evidence of low uptake of this intervention." | 3.83 | The challenge of using intermittent preventive therapy with sulfadoxine/pyrimethamine among pregnant women in Uganda. ( Katamba, H; Okullo, AE; Rubahika, D; Wanzira, H, 2016) |
| "Intermittent preventive treatment of malaria in pregnancy with 3+ doses of sulfadoxine-pyrimethamine (IPTp-SP) reduces maternal mortality and stillbirths in malaria endemic areas." | 3.83 | Scaling-up the use of sulfadoxine-pyrimethamine for the preventive treatment of malaria in pregnancy: results and lessons on scalability, costs and programme impact from three local government areas in Sokoto State, Nigeria. ( Abdul-Azeez, J; Abegunde, D; Austin, AM; Beal, K; Fapohunda, B; Ganiyu, H; Ibrahim, M; Mohammed, Z; Nanbol, Z; Orobaton, N, 2016) |
| "Owing to increasing sulfadoxine-pyrimethamine (SP) resistance in sub-Saharan Africa, monitoring the effectiveness of intermittent preventive therapy in pregnancy (IPTp) with SP is crucial." | 3.83 | Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness of Intermittent Preventive Therapy for Malaria in Pregnancy at Clearing Infections and Preventing Low Birth Weight. ( Ades, V; Arinaitwe, E; Chaluluka, E; Coulibaly, SO; Desai, M; Doumbo, O; Edgar, D; Gutman, J; Kalilani, L; Kamuliwo, M; Kayentao, K; Khairallah, C; Mace, KE; Magnussen, P; Mathanga, DP; Meshnick, S; Otieno, K; Ouma, P; Shi, YP; Skarbinski, J; Taylor, SM; Ter Kuile, FO; Wiegand, RE, 2016) |
| "Sulfadoxine/pyrimethamine did not reduce colonization rates when used as the IPTp drug during pregnancy." | 3.81 | Evaluation of intermittent preventive treatment of malaria against group B Streptococcus colonization in pregnant women: a nested analysis of a randomized controlled clinical trial of sulfadoxine/pyrimethamine versus mefloquine. ( Adegnika, AA; Agnandji, ST; Akerey-Diop, D; Basra, A; Bélard, S; Capan-Melser, M; González, R; Groger, M; Kremsner, PG; Lötsch, F; Mackanga, JR; Matsiegui, PB; Menendez, C; Mombo Ngoma, G; Ramharter, M; Rehman, K; Schipulle, U; Schwing, J; Würbel, H; Zoleko-Manego, R, 2015) |
| "Intermittent preventive treatment of malaria in pregnancy (IPTp) with sulphadoxine-pyrimethamine (SP) decreases adverse effects of malaria during pregnancy." | 3.80 | Efficacy of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy, Mansa, Zambia. ( Chalwe, V; Craig, AS; Filler, SJ; Kamuliwo, M; Katalenich, BL; Mace, KE; Meshnick, SR; Nambozi, M; Tan, KR; Taylor, SM; Wiegand, RE, 2014) |
| "The World Health Organization (WHO) recommends for sub-Saharan Africa a package of prompt and effective case-management combined with the delivery of insecticide-treated nets (ITN) and intermittent preventive treatment during pregnancy (IPTp) with sulphadoxine-pyrimethamine (SP) through the national antenatal care (ANC) programs." | 3.80 | Coverage and efficacy of intermittent preventive treatment with sulphadoxine pyrimethamine against malaria in pregnancy in Côte d'Ivoire five years after its implementation. ( Ako, BA; Bassinka, I; Beourou, S; Bokossa, EM; Coulibaly, B; Coulibaly, MA; Esmel, B; Gba, B; Gbessi, EA; Koffi, D; Kone, PL; N' Guessan, LT; Nogbou, M; Soumahoro, A; Swa, T; Toure, OA, 2014) |
| "Despite widespread parasite resistance to sulphadoxine-pyrimethamine (SP) its use for intermittent preventative treatment during pregnancy remains the policy in Benin and throughout most of sub-Saharan Africa." | 3.79 | High rates of parasite recrudescence following intermittent preventive treatment with sulphadoxine-pyrimethamine during pregnancy in Benin. ( Alifrangis, M; De Tove, YS; Deloron, P; Doritchamou, J; Luty, AJ; Massougbodji, A; Moussiliou, A; Ndam, NT, 2013) |
| "Millions of African women receive sulfadoxine-pyrimethamine (SP) as intermittent preventive treatment during pregnancy (IPTp) to avoid poor outcomes that result from malaria." | 3.77 | Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance. ( Duffy, PE; Fried, M; Harrington, WE; Kabyemela, E; Mutabingwa, TK, 2011) |
| "Effectiveness of cotrimoxazole (CTX) compared with sulfadoxine-pyrimethamine (SP) intermittent-preventive-therapy (IPTp) for malaria in HIV-infected pregnant women is unknown." | 3.77 | Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi. ( Fitzgerald, M; Kapito-Tembo, A; Meshnick, SR; Mwapasa, V; Phiri, K; van Hensbroek, MB, 2011) |
| "In this study, the intrinsic anti-bacterial activity of mefloquine and azithromycin was assessed in comparison to sulphadoxine-pyrimethamine against bacterial pathogens with clinical importance in pregnancy in a standard microdilution assay." | 3.76 | Anti-bacterial activity of intermittent preventive treatment of malaria in pregnancy: comparative in vitro study of sulphadoxine-pyrimethamine, mefloquine, and azithromycin. ( Capan, M; Makristathis, A; Mombo-Ngoma, G; Ramharter, M, 2010) |
| "Data on antenatal attendance, uptake of intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP), birthweight, malaria, anaemia, for 2,152 primigravidae." | 3.76 | Trends in pregnancy outcomes in Malawian adolescents receiving antimalarial and hematinic supplements. ( Brabin, BJ; D'Alessandro, U; Gies, S; Kalanda, G; Kazembe, P; Msyamboza, K; Savage, E, 2010) |
| "The relationship between antenatal care (ANC) visits and coverage of intermittent preventive treatment of malaria in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP), and barriers to IPTp-SP access were examined." | 3.76 | Intermittent preventive treatment of malaria in pregnancy (IPTp): do frequent antenatal care visits ensure access and compliance to IPTp in Ugandan rural communities? ( Katamanywa, J; Ndyomugyenyi, R, 2010) |
| "To assess whether traditional birth attendants, drug-shop vendors, community reproductive health workers and adolescent peer mobilizers can administer intermittent preventive treatment (IPT) with sulfadoxine-pyremethamine to pregnant women, and reach those most at risk of malaria and increase access and compliance to it." | 3.74 | Intermittent preventive treatment of malaria in pregnancy: the effect of new delivery approaches on access and compliance rates in Uganda. ( Bygbjerg, IB; Magnussen, P; Mbonye, AK, 2007) |
| "To assess whether traditional birth attendants, drug-shop vendors, community reproductive health workers and adolescent peer mobilizers can administer IPTp with sulphadoxine-pyrimethamine (SP) to pregnant women, reach those at greatest risk of malaria, and increase access and compliance with IPTp." | 3.74 | Effect of a community-based delivery of intermittent preventive treatment of malaria in pregnancy on treatment seeking for malaria at health units in Uganda. ( Bygbjerg, IC; Magnussen, P; Mbonye, AK; Schultz Hansen, K, 2008) |
| "Anaemia [haemoglobin (Hb) <11 g/dl), severe anaemia (Hb <8 g/dl) and placental malaria were compared among women with known HIV status who delivered at a provincial hospital after study enrolment in the third trimester during three consecutive periods: period 1, no routine intervention (reference); period 2, routine haematinic supplementation (60 mg elementary iron three times/day, folic acid 5 mg once daily) and period 3, haematinics and IPT with SP." | 3.74 | Effect of haematinic supplementation and malaria prevention on maternal anaemia and malaria in western Kenya. ( Ayisi, JG; Kager, PA; Nahlen, BL; Otieno, JA; Rosen, DH; Shi, YP; Slutsker, L; Steketee, RW; Ter Kuile, FO; van Eijk, AM, 2007) |
| "To monitor the effectiveness of intermittent preventive treatment (IPT) with sulphadoxine-pyrimethamine (SP) for the control of malaria in pregnancy at delivery in the Provincial Hospital in Kisumu, Kenya, and to assess the effect of IPT in participants in a cohort study." | 3.72 | Effectiveness of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in western Kenya: a hospital-based study. ( Ayisi, JG; Kager, PA; Misore, AO; Nahlen, BL; Odondi, JO; Otieno, JA; Rosen, DH; Steketee, RW; ter Kuile, FO; van Eijk, AM, 2004) |
| " Malaria prevalence at delivery remained high in HIV-infected women despite prior routine treatment with sulphadoxine-pyrimethamine in pregnancy There was no significant difference in parasite prevalence at delivery between women who did or did not use sulphadoxine-pyrimethamine." | 3.70 | Increased prevalence of malaria in HIV-infected pregnant women and its implications for malaria control. ( Brabin, BJ; Broadhead, RL; Chimsuku, L; Hart, CA; Kazembe, P; Verhoeff, FH, 1999) |
| " In case of maternal contamination after 33 weeks of pregnancy, pyrimethamine-sulfadiazine combination should be used in spite of its potential toxicity." | 3.67 | New perspectives in the chemoprophylaxis of toxoplasmosis. ( Garin, JP; Piens, MA, 1989) |
| " However, the optimal dosing regimen in settings in which human immunodeficiency virus (HIV) is highly prevalent among pregnant women remains controversial." | 2.73 | Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women. ( Chalwe, V; Champo, D; Chilengi, R; Gill, CJ; Hamer, DH; Macleod, WB; Mubikayi, L; Mukwamataba, D; Mulele, CK; Mulenga, M; Mwanakasale, V; Mwananyanda, L; Thea, DM, 2007) |
| "Effective intermittent preventive treatment in pregnancy (IPTp) diminishes placental malaria (PM) and its subsequent malaria-associated morbidity." | 2.50 | Pregnancy-associated malaria and malaria in infants: an old problem with present consequences. ( Abellana, R; Cot, M; Moya-Alvarez, V, 2014) |
| "Pregnancy is also associated with the risk of neural tube defects (NTDs), especially in women with low folate status, and folic acid supplementation is recommended in pregnancy to lower the risk of NTDs." | 2.50 | Impact of folate supplementation on the efficacy of sulfadoxine/pyrimethamine in preventing malaria in pregnancy: the potential of 5-methyl-tetrahydrofolate. ( Molloy, AM; Nzila, A; Okombo, J, 2014) |
| "Malaria in pregnancy is a significant contributor to adverse pregnancy outcome, especially in Sub-Saharan Africa." | 2.49 | A systematic review of the impact of malaria prevention in pregnancy on low birth weight and maternal anemia. ( Dent, AE; Goldenberg, RL; McClure, EM; Meshnick, SR, 2013) |
| " In the second and third trimesters, AL was not associated with increased adverse pregnancy outcomes as compared with quinine or sulphadoxine-pyrimethamine, showed improved tolerability relative to quinine, and its efficacy was non-inferior to quinine." | 2.48 | A systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancy. ( D'Alessandro, U; Hamed, K; Juma, E; Kayentao, K; Manyando, C; Okafor, HU, 2012) |
| "Malaria is frequently a deadly disease, particularly in tropical countries of the world where this protozoan infection is endemic." | 2.41 | Malaria: a rising incidence in the United States. ( Broder, JS; Colletti, JE; Geroff, AJ; Grundmann, KA; Hanna, JR; Jerrard, DA; Mattu, A, 2002) |
| "Twenty newborns had congenital toxoplasmosis: 19 cases were diagnosed by serology and one case was diagnosed after amniocentesis." | 1.48 | [Management of Toxoplasmic Seroconversion in the Third Trimester of Pregnancy in Tunisia]. ( Aoun, K; Ben Abdallah, R; Bouhlel, S; Bouratbine, A; Maatoug, R; Souissi, O, 2018) |
| "Prompt and effective treatment of malaria in pregnancy in accordance with recommended guidelines is essential to help prevent adverse events among pregnant mothers and the foetus." | 1.43 | Antimalarial treatment patterns among pregnant women attending antenatal care clinics in south east Nigeria and the future implications. ( Esimone, C; Ezenduka, C; Godman, BB; Massele, A; Nworgu, C, 2016) |
| "Malaria in pregnancy is an immense public health problem with at least 50 million pregnant women living in malaria endemic areas." | 1.43 | Assessment of the usage and effectiveness of intermittent preventive treatment and insecticide-treated nets on the indicators of malaria among pregnant women attending antenatal care in the Buea Health District, Cameroon. ( Anchang-Kimbi, JK; Fokam, EB; Ngimuh, L; Wanji, S, 2016) |
| "Question Congenital toxoplasmosis is a dangerous fetal infection." | 1.40 | Toxoplasmosis and pregnancy. ( Chaudhry, SA; Gad, N; Koren, G, 2014) |
| "Intermittent preventive treatment of malaria in pregnancy (IPTp) is a strategy where pregnant women in malaria-endemic countries receive full doses of sulphadoxine-pyrimethamine (SP), whether or not they have malaria." | 1.39 | Perceptions of intermittent preventive treatment of malaria in pregnancy (IPTp) and barriers to adherence in Nasarawa and Cross River States in Nigeria. ( Belay, KA; Diala, CC; Marin, C; Pennas, T, 2013) |
| "Malaria in pregnancy is a major health problem that can cause maternal anaemia, stillbirth, spontaneous abortion, low birth weight and intra-uterine stunting." | 1.38 | Validity of self-reported use of sulphadoxine-pyrimethamine intermittent presumptive treatment during pregnancy (IPTp): a cross-sectional study. ( Kironde, F; Mirembe, F; Namusoke, F; Ntale, M; Wahlgren, M, 2012) |
| "Malaria is an important public health problem in Africa." | 1.37 | Field evaluation of the intermittent preventive treatment of malaria during pregnancy (IPTp) in Benin: evolution of the coverage rate since its implementation. ( Agboton-Zoumenou, MA; Briand, V; Cottrell, G; d'Almeida, TC; Garcia, A; Imorou, Y; Massougbodji, A, 2011) |
| "The burden of malaria is greatest in sub-Saharan Africa where it contributes directly or indirectly to maternal and perinatal morbidity and mortality." | 1.35 | The challenges of diagnosis and treatment of malaria in pregnancy in low resource settings. ( Abe, E; Feyi-Waboso, P; Okonofua, FE; Omo-Aghoja, LO, 2008) |
| "Fifty-seven cases of congenital toxoplasmosis were demonstrated (34." | 1.31 | Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests. ( Berrebi, A; Bessières, MH; Bloom, MC; Cassaing, S; Courjault, C; Rolland, M; Roques, C; Séguéla, JP, 2001) |
| "Prevention of congenital toxoplasmosis is obtained by educating pregnant women at risk about how to prevent the infection and by diagnosing acute infection of mother." | 1.28 | [Prevention of congenital toxoplasmosis]. ( Galanti, B; Russo, M, 1990) |
| " Reappraisal of quinine therapy has led to important modifications in dosage recommendations and recognition of a major complication of severe malaria associated with its use--hypoglycaemia." | 1.27 | Management of Plasmodium falciparum malaria. ( Phillips, RE, 1984) |
| "Chloroquine resistance was confirmed by testing in vitro and in vivo." | 1.27 | Multiple drug resistant Plasmodium falciparum malaria in a pregnant indigenous Zambian woman. ( Rolfe, M, 1988) |
| "Two newborn infants with congenital toxoplasmosis despite serological testing during pregnancy were observed at our premature and neonatal intensive care unit within a short time of one another." | 1.26 | [Congenital toxoplasmosis in two newborn infants (author's transl)]. ( Coradello, H; Lubec, G; Simbruner, G, 1981) |
| "Even simple lymphadenitis during pregnancy may possibly be an acquired lymphatic form of toxoplasmosis with all detrimental consequences to the foetus." | 1.26 | [Lymphadenitis caused by toxoplasmosis during gravidity -- an aetiological factor in congenital damage to the child (author's transl)]. ( Kouba, K; Lasovská, J; Moravcová, E, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 76 (44.97) | 18.7374 |
| 1990's | 8 (4.73) | 18.2507 |
| 2000's | 25 (14.79) | 29.6817 |
| 2010's | 58 (34.32) | 24.3611 |
| 2020's | 2 (1.18) | 2.80 |
| Authors | Studies |
|---|---|
| Spracklen, FH | 2 |
| Monteagudo, FS | 1 |
| Panton, LJ | 1 |
| Tulloch, S | 1 |
| Bradley, AK | 1 |
| Greenwood, BM | 1 |
| Unger, HW | 1 |
| Rosanas-Urgell, A | 1 |
| Robinson, LJ | 1 |
| Ome-Kaius, M | 1 |
| Jally, S | 1 |
| Umbers, AJ | 1 |
| Pomat, W | 1 |
| Mueller, I | 1 |
| Kattenberg, E | 1 |
| Rogerson, SJ | 1 |
| Searle, AR | 1 |
| Hurley, EA | 1 |
| Doumbia, SO | 1 |
| Winch, PJ | 1 |
| Yaya, S | 1 |
| Kota, K | 1 |
| Buh, A | 1 |
| Bishwajit, G | 1 |
| Minuzzi, CE | 1 |
| Portella, LP | 1 |
| Bräunig, P | 1 |
| Sangioni, LA | 1 |
| Ludwig, A | 1 |
| Ramos, LS | 1 |
| Pacheco, L | 1 |
| Silva, CR | 1 |
| Pacheco, FC | 1 |
| Menegolla, IA | 1 |
| Farinha, LB | 1 |
| Kist, PP | 1 |
| Breganó, RM | 1 |
| Nino, BSL | 1 |
| Cardoso Martins, FD | 1 |
| Monica, TC | 1 |
| Ferreira, FP | 1 |
| Britto, I | 1 |
| Signori, A | 1 |
| Medici, KC | 1 |
| Freire, RL | 1 |
| Garcia, JL | 1 |
| Navarro, IT | 1 |
| Difante, CM | 1 |
| Flores Vogel, FS | 1 |
| Chico, RM | 1 |
| Chaponda, EB | 1 |
| Ariti, C | 1 |
| Chandramohan, D | 2 |
| Ojurongbe, O | 1 |
| Nguetse, CN | 1 |
| Fayemiwo, SA | 1 |
| Falade, CO | 2 |
| Ojurongbe, TA | 1 |
| Thomas, BN | 1 |
| Meyer, CG | 1 |
| Velavan, TP | 1 |
| Hallamaa, L | 2 |
| Cheung, YB | 2 |
| Maleta, K | 1 |
| Luntamo, M | 3 |
| Ashorn, U | 2 |
| Gladstone, M | 1 |
| Kulmala, T | 2 |
| Mangani, C | 2 |
| Ashorn, P | 3 |
| Boudaouara, Y | 1 |
| Aoun, K | 2 |
| Maatoug, R | 2 |
| Souissi, O | 2 |
| Bouratbine, A | 2 |
| Abdallah, RB | 1 |
| Mandelbrot, L | 1 |
| Kieffer, F | 1 |
| Sitta, R | 1 |
| Laurichesse-Delmas, H | 1 |
| Winer, N | 1 |
| Mesnard, L | 1 |
| Berrebi, A | 3 |
| Le Bouar, G | 1 |
| Bory, JP | 1 |
| Cordier, AG | 1 |
| Ville, Y | 1 |
| Perrotin, F | 1 |
| Jouannic, JM | 1 |
| Biquard, F | 1 |
| d'Ercole, C | 1 |
| Houfflin-Debarge, V | 1 |
| Villena, I | 1 |
| Thiébaut, R | 1 |
| Rassi, C | 2 |
| Gore-Langton, GR | 1 |
| Gidudu Walimbwa, B | 1 |
| Strachan, CE | 1 |
| King, R | 2 |
| Basharat, S | 1 |
| Christiansen-Jucht, C | 1 |
| Graham, K | 2 |
| Gudoi, SS | 2 |
| González, R | 2 |
| Pons-Duran, C | 1 |
| Piqueras, M | 1 |
| Aponte, JJ | 1 |
| Ter Kuile, FO | 8 |
| Menéndez, C | 4 |
| Bouhlel, S | 1 |
| Ben Abdallah, R | 1 |
| Kayentao, K | 6 |
| Garner, P | 1 |
| van Eijk, AM | 4 |
| Naidoo, I | 1 |
| Roper, C | 2 |
| Mulokozi, A | 1 |
| MacArthur, JR | 1 |
| Doumbo, OK | 3 |
| Tsoka-Gwegweni, JM | 1 |
| Kleinschmidt, I | 1 |
| McClure, EM | 1 |
| Goldenberg, RL | 1 |
| Dent, AE | 1 |
| Meshnick, SR | 3 |
| Moussiliou, A | 1 |
| De Tove, YS | 1 |
| Doritchamou, J | 1 |
| Luty, AJ | 2 |
| Massougbodji, A | 3 |
| Alifrangis, M | 1 |
| Deloron, P | 1 |
| Ndam, NT | 2 |
| Webster, J | 2 |
| Bruce, J | 2 |
| Diawara, SI | 1 |
| Abathina, A | 1 |
| Haiballa, AA | 1 |
| Hill, J | 3 |
| White, NJ | 1 |
| Pukrittayakamee, S | 1 |
| Hien, TT | 1 |
| Faiz, MA | 1 |
| Mokuolu, OA | 1 |
| Dondorp, AM | 1 |
| Diala, CC | 1 |
| Pennas, T | 1 |
| Marin, C | 1 |
| Belay, KA | 1 |
| Nzila, A | 2 |
| Okombo, J | 1 |
| Molloy, AM | 1 |
| Chaudhry, SA | 1 |
| Gad, N | 1 |
| Koren, G | 1 |
| Tan, KR | 1 |
| Katalenich, BL | 1 |
| Mace, KE | 2 |
| Nambozi, M | 1 |
| Taylor, SM | 2 |
| Wiegand, RE | 2 |
| Chalwe, V | 3 |
| Filler, SJ | 2 |
| Kamuliwo, M | 2 |
| Craig, AS | 1 |
| Moya-Alvarez, V | 1 |
| Abellana, R | 1 |
| Cot, M | 2 |
| Cohee, LM | 1 |
| Kalilani-Phiri, L | 1 |
| Boudova, S | 1 |
| Joshi, S | 1 |
| Mukadam, R | 1 |
| Seydel, KB | 1 |
| Mawindo, P | 1 |
| Thesing, P | 1 |
| Kamiza, S | 1 |
| Makwakwa, K | 1 |
| Muehlenbachs, A | 1 |
| Taylor, TE | 1 |
| Laufer, MK | 1 |
| Toure, OA | 1 |
| Kone, PL | 1 |
| Coulibaly, MA | 1 |
| Ako, BA | 1 |
| Gbessi, EA | 1 |
| Coulibaly, B | 1 |
| N' Guessan, LT | 1 |
| Koffi, D | 1 |
| Beourou, S | 1 |
| Soumahoro, A | 1 |
| Bassinka, I | 1 |
| Nogbou, M | 1 |
| Swa, T | 1 |
| Gba, B | 1 |
| Esmel, B | 1 |
| Bokossa, EM | 1 |
| Mpogoro, FJ | 1 |
| Matovelo, D | 1 |
| Dosani, A | 1 |
| Ngallaba, S | 1 |
| Mugono, M | 1 |
| Mazigo, HD | 1 |
| Capan-Melser, M | 1 |
| Mombo Ngoma, G | 1 |
| Akerey-Diop, D | 1 |
| Basra, A | 1 |
| Würbel, H | 1 |
| Groger, M | 1 |
| Mackanga, JR | 1 |
| Zoleko-Manego, R | 1 |
| Schipulle, U | 1 |
| Schwing, J | 1 |
| Lötsch, F | 1 |
| Rehman, K | 1 |
| Matsiegui, PB | 1 |
| Agnandji, ST | 1 |
| Adegnika, AA | 1 |
| Bélard, S | 1 |
| Kremsner, PG | 1 |
| Ramharter, M | 2 |
| Chauvin, P | 1 |
| Menard, S | 1 |
| Iriart, X | 1 |
| Nsango, SE | 1 |
| Tchioffo, MT | 1 |
| Abate, L | 1 |
| Awono-Ambéné, PH | 1 |
| Morlais, I | 1 |
| Berry, A | 1 |
| Ibitokou, SA | 1 |
| Denoeud-Ndam, L | 1 |
| Ezinmegnon, S | 1 |
| Ladékpo, R | 1 |
| Zannou, DM | 1 |
| Girard, PM | 1 |
| Bouyou-Akotet, MK | 2 |
| Tshibola, ML | 1 |
| Mawili-Mboumba, DP | 2 |
| Nzong, J | 1 |
| Bahamontes-Rosa, N | 1 |
| Tsoumbou-Bakana, G | 1 |
| Kombila, M | 2 |
| Desai, M | 2 |
| Gutman, J | 3 |
| Khairallah, C | 1 |
| Ouma, P | 2 |
| Coulibaly, SO | 2 |
| Kalilani, L | 1 |
| Arinaitwe, E | 1 |
| Mathanga, DP | 2 |
| Doumbo, O | 2 |
| Otieno, K | 2 |
| Edgar, D | 1 |
| Chaluluka, E | 1 |
| Ades, V | 1 |
| Skarbinski, J | 1 |
| Shi, YP | 3 |
| Magnussen, P | 4 |
| Meshnick, S | 1 |
| Fokam, EB | 1 |
| Ngimuh, L | 1 |
| Anchang-Kimbi, JK | 1 |
| Wanji, S | 1 |
| Mufubenga, P | 1 |
| Meier, J | 1 |
| Wanzira, H | 1 |
| Katamba, H | 1 |
| Okullo, AE | 1 |
| Rubahika, D | 1 |
| Orobaton, N | 1 |
| Austin, AM | 1 |
| Abegunde, D | 1 |
| Ibrahim, M | 1 |
| Mohammed, Z | 1 |
| Abdul-Azeez, J | 1 |
| Ganiyu, H | 1 |
| Nanbol, Z | 1 |
| Fapohunda, B | 1 |
| Beal, K | 1 |
| Oguike, MC | 1 |
| Shu, E | 1 |
| Enato, IG | 1 |
| Watila, I | 1 |
| Baba, ES | 1 |
| Hamade, P | 1 |
| Meek, S | 1 |
| Sutherland, CJ | 1 |
| Warhurst, D | 1 |
| Slutsker, L | 4 |
| Ezenduka, C | 1 |
| Nworgu, C | 1 |
| Godman, BB | 1 |
| Massele, A | 1 |
| Esimone, C | 1 |
| Mwendera, CA | 1 |
| de Jager, C | 1 |
| Longwe, H | 1 |
| Phiri, K | 2 |
| Hongoro, C | 1 |
| Mutero, CM | 1 |
| Omo-Aghoja, LO | 1 |
| Abe, E | 1 |
| Feyi-Waboso, P | 1 |
| Okonofua, FE | 1 |
| Naniche, D | 1 |
| Lahuerta, M | 1 |
| Bardaji, A | 2 |
| Sigauque, B | 2 |
| Romagosa, C | 1 |
| Berenguera, A | 1 |
| Mandomando, I | 2 |
| David, C | 1 |
| Sanz, S | 2 |
| Aponte, J | 1 |
| Ordi, J | 1 |
| Alonso, P | 1 |
| Gies, S | 2 |
| Ouattara, FT | 1 |
| Ky, C | 1 |
| Brabin, BJ | 4 |
| D'Alessandro, U | 3 |
| Tiono, AB | 2 |
| Ouedraogo, A | 2 |
| Bougouma, EC | 2 |
| Diarra, A | 2 |
| Konaté, AT | 2 |
| Nébié, I | 2 |
| Sirima, SB | 2 |
| Tchantchou, Tde D | 1 |
| Ndyomugyenyi, R | 1 |
| Katamanywa, J | 1 |
| Msyamboza, K | 1 |
| Savage, E | 1 |
| Kalanda, G | 1 |
| Kazembe, P | 4 |
| Assouline, C | 1 |
| Bessières, MH | 2 |
| Lathière, M | 1 |
| Cassaing, S | 2 |
| Minville, V | 1 |
| Ayoubi, JM | 1 |
| Capan, M | 1 |
| Mombo-Ngoma, G | 1 |
| Makristathis, A | 1 |
| Serra-Casas, E | 1 |
| Scahill, MD | 1 |
| Nhabomba, A | 1 |
| Cisteró, P | 1 |
| Dobaño, C | 1 |
| Alonso, PL | 1 |
| Mayor, A | 1 |
| Kapito-Tembo, A | 1 |
| van Hensbroek, MB | 1 |
| Fitzgerald, M | 1 |
| Mwapasa, V | 1 |
| Maiga, AS | 1 |
| Diakite, M | 1 |
| Diawara, A | 1 |
| Sango, HA | 1 |
| Coulibaly, CO | 1 |
| Akinleye, SO | 1 |
| Ajayi, IO | 1 |
| d'Almeida, TC | 1 |
| Agboton-Zoumenou, MA | 1 |
| Garcia, A | 1 |
| Briand, V | 1 |
| Imorou, Y | 1 |
| Cottrell, G | 1 |
| Diakite, OS | 1 |
| Maiga, OM | 1 |
| Traoré, BT | 1 |
| Djimde, A | 1 |
| Traoré, B | 1 |
| Diallo, M | 2 |
| Traoré, M | 1 |
| Ongoiba, A | 2 |
| Doumtabé, D | 1 |
| Doumbo, S | 1 |
| Traoré, MS | 1 |
| Dara, A | 1 |
| Guindo, O | 1 |
| Karim, DM | 1 |
| Coulibaly, S | 1 |
| Bougoudogo, F | 1 |
| Danis, M | 1 |
| Harrington, WE | 1 |
| Mutabingwa, TK | 1 |
| Kabyemela, E | 1 |
| Fried, M | 1 |
| Duffy, PE | 1 |
| Leke, RG | 1 |
| Taylor, DW | 1 |
| Randriambelomanana, JA | 1 |
| Rakotoarisoa, H | 1 |
| Herinirina, SA | 1 |
| Zafindravola, BA | 1 |
| Andrianampanalinarivo, HR | 1 |
| Uthman, OA | 1 |
| Chinkhumba, J | 1 |
| Kachur, SP | 1 |
| Mutabingwa, T | 1 |
| Iriemenam, NC | 1 |
| Shah, M | 1 |
| Gatei, W | 1 |
| Ayisi, J | 1 |
| Kariuki, S | 1 |
| Vanden Eng, J | 1 |
| Owino, SO | 1 |
| Lal, AA | 1 |
| Omosun, YO | 1 |
| Nahlen, B | 1 |
| Moore, J | 1 |
| Hamel, MJ | 1 |
| Manyando, C | 1 |
| Okafor, HU | 1 |
| Juma, E | 1 |
| Hamed, K | 1 |
| Namusoke, F | 1 |
| Ntale, M | 1 |
| Wahlgren, M | 1 |
| Kironde, F | 1 |
| Mirembe, F | 1 |
| Jerrard, DA | 1 |
| Broder, JS | 1 |
| Hanna, JR | 1 |
| Colletti, JE | 1 |
| Grundmann, KA | 1 |
| Geroff, AJ | 1 |
| Mattu, A | 1 |
| DELERUE, J | 1 |
| MORLEY, D | 1 |
| WOODLAND, M | 1 |
| CUTHBERTSON, WF | 1 |
| BEER, K | 1 |
| OCKLITZ, HW | 1 |
| SCHMITZ, HH | 1 |
| ZIESCHE, H | 1 |
| MOHR, W | 1 |
| PIEKARSKI, G | 1 |
| TENHUNEN, A | 1 |
| ALEXANDER, M | 2 |
| PULLON, DH | 1 |
| KRAEUBIG, H | 1 |
| Holland, GN | 1 |
| Ayisi, JG | 2 |
| Otieno, JA | 2 |
| Misore, AO | 1 |
| Odondi, JO | 1 |
| Rosen, DH | 2 |
| Kager, PA | 2 |
| Steketee, RW | 4 |
| Nahlen, BL | 3 |
| Flori, P | 1 |
| Tardy, L | 1 |
| Patural, H | 1 |
| Bellete, B | 1 |
| Varlet, MN | 1 |
| Hafid, J | 1 |
| Raberin, H | 1 |
| Sung, RT | 1 |
| Bachmeyer, C | 1 |
| Mouchnino, G | 1 |
| Thulliez, P | 2 |
| Blum, L | 1 |
| Di Carlo, P | 1 |
| Mazzola, A | 1 |
| Romano, A | 1 |
| Schimmenti, MG | 1 |
| Colicchia, P | 1 |
| Bellipanni, P | 1 |
| Titone, L | 1 |
| Kalanda, GC | 1 |
| Verhoeff, FH | 2 |
| Thigpen, M | 1 |
| Macheso, A | 1 |
| Parise, ME | 1 |
| Newman, RD | 1 |
| Hamel, M | 1 |
| Mbonye, AK | 3 |
| Bygbjerg, IB | 1 |
| Bygbjerg, IC | 2 |
| Nyunt, MM | 1 |
| Plowe, CV | 1 |
| Gill, CJ | 2 |
| Macleod, WB | 2 |
| Mwanakasale, V | 2 |
| Mwananyanda, L | 2 |
| Champo, D | 2 |
| Mukwamataba, D | 2 |
| Chilengi, R | 2 |
| Thea, DM | 2 |
| Hamer, DH | 2 |
| Mubikayi, L | 1 |
| Mulele, CK | 1 |
| Mulenga, M | 1 |
| Brentlinger, PE | 1 |
| Dgedge, M | 1 |
| Correia, MA | 1 |
| Rojas, AJ | 1 |
| Saúte, F | 1 |
| Gimbel-Sherr, KH | 1 |
| Stubbs, BA | 1 |
| Mercer, MA | 1 |
| Gloyd, S | 1 |
| Dabo, CA | 1 |
| Saye, R | 1 |
| Yattara, O | 1 |
| Diarra, MA | 1 |
| Sangho, H | 1 |
| Schultz Hansen, K | 1 |
| Ivanov, I | 1 |
| Dimitrov, DIa | 1 |
| Giurovski, S | 1 |
| Harpey, JP | 1 |
| Main, EK | 1 |
| Main, DM | 1 |
| Krogstad, DJ | 2 |
| Phillips, RE | 1 |
| Thalhammer, O | 1 |
| van der Veen, J | 1 |
| Stagno, S | 1 |
| Bonardi, R | 1 |
| Feberwee, JD | 1 |
| Grio, R | 1 |
| Piacentino, R | 1 |
| Corbella, O | 1 |
| Tagliati, D | 1 |
| De Pascale, A | 1 |
| Coradello, H | 1 |
| Lubec, G | 1 |
| Simbruner, G | 1 |
| Gilles, HM | 1 |
| Furmaniuk, J | 1 |
| Religa, Z | 1 |
| Kiełek, M | 1 |
| Siemiński, R | 1 |
| Koszałkowski, M | 1 |
| Szuba, R | 1 |
| Walkowska, I | 1 |
| Szymonik, Z | 1 |
| Ibeziako, PA | 1 |
| Williams, AI | 1 |
| Switala, I | 1 |
| Dufour, P | 1 |
| Ducloy, AS | 1 |
| Vinatier, D | 1 |
| Bernardi, C | 1 |
| Monnier, JC | 1 |
| Plantier, I | 1 |
| Fortier, B | 1 |
| Hart, CA | 1 |
| Chimsuku, L | 1 |
| Broadhead, RL | 1 |
| Rolland, M | 1 |
| Bloom, MC | 1 |
| Roques, C | 1 |
| Courjault, C | 1 |
| Séguéla, JP | 1 |
| Kouba, K | 2 |
| Lasovská, J | 2 |
| Moravcová, E | 1 |
| Miller, EC | 1 |
| Kräubig, H | 1 |
| Katz, D | 1 |
| Plank, G | 1 |
| Jankó, M | 1 |
| Nemes, J | 1 |
| Quinn, EL | 1 |
| Fisher, EJ | 1 |
| Cox, F | 1 |
| Madhavan, T | 1 |
| Cengir, SD | 1 |
| Ortaç, F | 1 |
| Söylemez, F | 1 |
| Russo, M | 1 |
| Galanti, B | 1 |
| Keuter, M | 1 |
| van Eijk, A | 1 |
| Hoogstrate, M | 1 |
| Raasveld, M | 1 |
| van de Ree, M | 1 |
| Ngwawe, WA | 1 |
| Watkins, WM | 1 |
| Were, JB | 1 |
| Brandling-Bennett, AD | 1 |
| Pajor, A | 1 |
| Wilson, CB | 1 |
| Mitchell, CD | 1 |
| Erlich, SS | 1 |
| Mastrucci, MT | 1 |
| Hutto, SC | 1 |
| Parks, WP | 1 |
| Scott, GB | 1 |
| Akintunde, A | 1 |
| Alakija, T | 1 |
| Nguyen-Dinh, P | 1 |
| Ogunbode, O | 1 |
| Edungbola, LD | 1 |
| Adetoro, O | 1 |
| Breman, JG | 1 |
| Hohlfeld, P | 1 |
| Daffos, F | 1 |
| Aufrant, C | 1 |
| Couvreur, J | 3 |
| MacAleese, J | 1 |
| Descombey, D | 1 |
| Forestier, F | 1 |
| Piens, MA | 1 |
| Garin, JP | 1 |
| Rolfe, M | 1 |
| Scheibe, J | 1 |
| Schulz, KR | 1 |
| Kupferschmidt, HG | 1 |
| Minoprio, JL | 1 |
| Murura, F | 1 |
| Haedo, JT | 1 |
| Peiretti, JA | 1 |
| Zagaĭnova, MN | 1 |
| Wilkowske, CJ | 1 |
| Hermans, PE | 1 |
| Desmonts, G | 2 |
| Fuchs, F | 1 |
| Kimball, AC | 1 |
| Kean, BH | 1 |
| Carollo, F | 1 |
| Spanó, C | 1 |
| Dardanoni, L | 1 |
| Sharf, M | 1 |
| Eibschitz, I | 1 |
| Eylan, E | 1 |
| Pakan, J | 4 |
| Handzo, I | 3 |
| Vierik, J | 1 |
| Markus, MB | 1 |
| Kupka, S | 2 |
| Poindexter, HA | 1 |
| Gerula, I | 1 |
| Gregus, E | 1 |
| Sílesová, J | 1 |
| Skála, V | 1 |
| Augustín, J | 1 |
| Vojta, M | 1 |
| Avratová, L | 1 |
| Balák, K | 1 |
| Fuchs, V | 1 |
| Raffaj, J | 1 |
| Schmidt, K | 1 |
| Tolentino, P | 1 |
| Hogan, MJ | 2 |
| Hengst, P | 1 |
| Maresová, V | 1 |
| Juranek, DD | 1 |
| Walls, KW | 1 |
| Drazkowski, H | 2 |
| Kuźmiński, R | 1 |
| Nowak, A | 1 |
| Zawadzki, J | 1 |
| Luk'ianova, KP | 1 |
| Boughton, CR | 1 |
| Sfetsos, M | 1 |
| Shitova, EM | 2 |
| Kulikova, KV | 1 |
| Zabugin, FD | 1 |
| Krahe, M | 1 |
| Schröter, RM | 1 |
| Hammer, B | 1 |
| Wegmann, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Lungwena Antenatal Intervention Study. A Single-centre Intervention Trial in Rural Malawi, Testing Maternal and Infant Health Effects of Presumptive Intermittent Treatment of Pregnant Women With Sulfadoxine-pyrimethamine and Azithromycin[NCT00131235] | Phase 3 | 1,320 participants (Actual) | Interventional | 2003-12-31 | Active, not recruiting | ||
| Community-based Scheduled Screening and Treatment of Malaria in Pregnancy for Improved Maternal and Infant Health: a Cluster-randomized Trial in The Gambia, Burkina Faso and Benin[NCT01941264] | 4,265 participants (Actual) | Interventional | 2013-10-31 | Completed | |||
| Operational Feasibility, Impact of Additional Screening Using Highly-sensitives RDTs Combined With High Coverage of IPTp on Placental Malaria and Low Birth Weight[NCT04147546] | Phase 3 | 340 participants (Actual) | Interventional | 2020-08-31 | Completed | ||
| Scaling up the Use of Sulphadoxine-Pyrimethamine for the Preventive Treatment of Malaria in Pregnancy: Results and Lessons on Scalability, Costs and Program From Three Local Government Areas in Sokoto State, Nigeria[NCT02758353] | 31,493 participants (Actual) | Interventional | 2015-04-30 | Completed | |||
| Incorporation of the 'Ottawa Malaria Decision Aid' Into the Pre-travel Consultation Process: Assessment of Travelers' Knowledge, Decisional Conflict, Preparation for Decision-making and Medication Adherence Compared to Standard Care[NCT01976325] | 100 participants (Anticipated) | Interventional | 2014-01-31 | Recruiting | |||
| Infections in Migrants in Sweden - the Importance of Malaria and Other Parasitic Infections[NCT05086887] | 715 participants (Anticipated) | Observational [Patient Registry] | 2019-04-15 | Recruiting | |||
| Clinical Efficacy of Artemisinin-based Combination Therapy for Treatment of Uncomplicated Plasmodium Falciparum Malaria in North Sumatera, Indonesia and the Association of Molecular Markers With Treatment Outcomes[NCT02325180] | Phase 4 | 338 participants (Actual) | Interventional | 2015-01-31 | Completed | ||
| Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity[NCT05757167] | Phase 4 | 2,500 participants (Anticipated) | Interventional | 2023-11-06 | Recruiting | ||
| Effect of Single-course Malaria Chemoprevention on Clearance of and Protection From Plasmodium Falciparum Infection in the Presence of Resistance-associated Genotypes in Zambia[NCT06166498] | Phase 3 | 600 participants (Anticipated) | Interventional | 2024-02-15 | Not yet recruiting | ||
| Effect of Single-course Malaria Chemoprevention on Clearance of and Protection From Plasmodium Falciparum Infection in the Presence of Resistance-associated Genotypes in Cameroon[NCT06173206] | Phase 3 | 900 participants (Anticipated) | Interventional | 2024-03-15 | Not yet recruiting | ||
| Assessing the Prevalence and Impact of Dihydropteroate Synthase-431V Mutation on the Protective Efficacy of Intermittent Preventive Treatment During Pregnancy Using Sulphadoxine-pyrimethamine[NCT04634695] | 288 participants (Anticipated) | Observational [Patient Registry] | 2020-08-10 | Recruiting | |||
| Effect of Intermittent Preventive Treatment (IPTp) With Sulfadoxine-Pyrimethamine Plus Insecticide Treated Nets, Delivered Through Antenatal Clinics for the Prevention of Malaria in Mozambican Pregnant Women[NCT00209781] | 1,028 participants | Interventional | 2003-08-31 | Active, not recruiting | |||
| Comparison of IST Using Ultra-sensitive Malaria Rapid Diagnostic Test and Pyronaridine - Artesunate - PYRAMAX®) to Standard IPT Sulfadoxine-pyrimethamine to Prevent Malaria in Pregnant Women Living in Endemic Areas[NCT04783051] | Phase 3 | 250 participants (Actual) | Interventional | 2021-05-06 | Completed | ||
| Intermittent Preventive Treatment With Sulfadoxine/Pyrimethamine During Pregnancy Among HIV-Positive and HIV-Negative Women: 2-Dose Versus Monthly - Malawi[NCT00126906] | 700 participants | Interventional | 2002-10-31 | Completed | |||
| Assessing the Effectiveness of Community Delivery of Intermittent Preventive Treatment in Pregnancy (IPTp) in Malawi[NCT03376217] | 1,447 participants (Actual) | Interventional | 2017-12-01 | Completed | |||
| Intermittent Preventive Treatment of Malaria With Sulfadoxine-Pyrimethamine in HIV-Seropositive and HIV-Seronegative Pregnant Women in Zambia[NCT00270530] | Phase 4 | 454 participants | Interventional | 2002-11-30 | Completed | ||
| Pharmacokinetics of Chlorproguanil-Dapsone in Pregnant Women With Plasmodium Falciparum Infection, and Reinfection With P. Falciparum During Pregnancy Following Treatment[NCT00126971] | Phase 1 | 132 participants | Interventional | 2005-07-31 | Suspended | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
18 reviews available for pyrimethamine and Complications, Infectious Pregnancy
| Article | Year |
|---|---|
Malaria 1984. Part I. Malaria prophylaxis.
Topics: Antimalarials; Chloroquine; Dapsone; Drug Combinations; Drug Resistance, Microbial; Female; Humans; | 1984 |
Mefloquine for preventing malaria in pregnant women.
Topics: Anemia; Antimalarials; Drug Combinations; Drug Therapy, Combination; Female; HIV Seronegativity; Hum | 2018 |
Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis.
Topics: Africa; Antimalarials; Drug Administration Schedule; Drug Combinations; Female; Humans; Infant, Low | 2013 |
A systematic review of the impact of malaria prevention in pregnancy on low birth weight and maternal anemia.
Topics: Africa South of the Sahara; Anemia; Antimalarials; Drug Combinations; Female; Humans; Infant, Low Bi | 2013 |
Malaria.
Topics: Africa South of the Sahara; Amodiaquine; Animals; Anopheles; Antimalarials; Artemisinins; Artesunate | 2014 |
Malaria.
Topics: Africa South of the Sahara; Amodiaquine; Animals; Anopheles; Antimalarials; Artemisinins; Artesunate | 2014 |
Malaria.
Topics: Africa South of the Sahara; Amodiaquine; Animals; Anopheles; Antimalarials; Artemisinins; Artesunate | 2014 |
Malaria.
Topics: Africa South of the Sahara; Amodiaquine; Animals; Anopheles; Antimalarials; Artemisinins; Artesunate | 2014 |
Malaria.
Topics: Africa South of the Sahara; Amodiaquine; Animals; Anopheles; Antimalarials; Artemisinins; Artesunate | 2014 |
Malaria.
Topics: Africa South of the Sahara; Amodiaquine; Animals; Anopheles; Antimalarials; Artemisinins; Artesunate | 2014 |
Malaria.
Topics: Africa South of the Sahara; Amodiaquine; Animals; Anopheles; Antimalarials; Artemisinins; Artesunate | 2014 |
Malaria.
Topics: Africa South of the Sahara; Amodiaquine; Animals; Anopheles; Antimalarials; Artemisinins; Artesunate | 2014 |
Malaria.
Topics: Africa South of the Sahara; Amodiaquine; Animals; Anopheles; Antimalarials; Artemisinins; Artesunate | 2014 |
Impact of folate supplementation on the efficacy of sulfadoxine/pyrimethamine in preventing malaria in pregnancy: the potential of 5-methyl-tetrahydrofolate.
Topics: Anencephaly; Animals; Antimalarials; Drug Combinations; Drug Therapy, Combination; Female; Folic Aci | 2014 |
Pregnancy-associated malaria and malaria in infants: an old problem with present consequences.
Topics: Adult; Africa South of the Sahara; Antimalarials; Comorbidity; Complement Activation; Developmental | 2014 |
Changing the policy for intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy in Malawi.
Topics: Antimalarials; Chemoprevention; Drug Combinations; Female; Health Policy; Humans; Malaria, Falciparu | 2017 |
Intermittent preventive treatment regimens for malaria in HIV-positive pregnant women.
Topics: Antimalarials; Drug Combinations; Female; HIV Seropositivity; Humans; Malaria; Pregnancy; Pregnancy | 2011 |
Combination of probenecid-sulphadoxine-pyrimethamine for intermittent preventive treatment in pregnancy.
Topics: Antimalarials; Chemoprevention; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malari | 2012 |
A systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancy.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Drug-Rela | 2012 |
Malaria: a rising incidence in the United States.
Topics: Antimalarials; Chemoprevention; Chloroquine; Drug Combinations; Drug Resistance; Female; Global Heal | 2002 |
Comparative efficacy of chloroquine and sulphadoxine--pyrimethamine in pregnant women and children: a meta-analysis.
Topics: Adolescent; Adult; Africa; Antimalarials; Child; Chloroquine; Drug Combinations; Endemic Diseases; F | 2006 |
[Toxoplasmosis and pregnancy].
Topics: Drug Therapy, Combination; Female; Fetal Diseases; Germany, West; Humans; Infant, Newborn; Pregnancy | 1976 |
Toxoplasmosis.
Topics: Animals; Child; Drug Administration Schedule; Female; Humans; Infant; Infant, Newborn; Pregnancy; Pr | 1976 |
Antimicrobial agents in the treatment of obstetric and gynecologic infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antifungal Agents; Cephalosporins; Chloramphenicol; Erythrom | 1974 |
[Recent advances in the epidemiology, clinical aspects and therapy of toxoplasmosis].
Topics: Abortion, Habitual; Drug Synergism; Electroencephalography; Female; Humans; Infant, Newborn; Leucomy | 1970 |
Ocular toxoplasmosis.
Topics: Abortion, Spontaneous; Adult; Animals; Diagnosis, Differential; Eye Diseases; Female; Humans; Hypers | 1969 |
19 trials available for pyrimethamine and Complications, Infectious Pregnancy
| Article | Year |
|---|---|
Microscopic and submicroscopic Plasmodium falciparum infection, maternal anaemia and adverse pregnancy outcomes in Papua New Guinea: a cohort study.
Topics: Adult; Anemia; Anti-Bacterial Agents; Antimalarials; Artemisinins; Asymptomatic Infections; Azithrom | 2019 |
Child Health Outcomes After Presumptive Infection Treatment in Pregnant Women: A Randomized Trial.
Topics: Adult; Anti-Bacterial Agents; Antimalarials; Azithromycin; Child Development; Child Health; Child Mo | 2018 |
Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial.
Topics: Adult; Antiprotozoal Agents; Drug Therapy, Combination; Female; France; Humans; Infectious Disease T | 2018 |
Community-based Malaria Screening and Treatment for Pregnant Women Receiving Standard Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: A Multicenter (The Gambia, Burkina Faso, and Benin) Cluster-randomized Controlled Trial.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Benin; Burkina Faso; Drug Combinati | 2019 |
Community-based Malaria Screening and Treatment for Pregnant Women Receiving Standard Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: A Multicenter (The Gambia, Burkina Faso, and Benin) Cluster-randomized Controlled Trial.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Benin; Burkina Faso; Drug Combinati | 2019 |
Community-based Malaria Screening and Treatment for Pregnant Women Receiving Standard Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: A Multicenter (The Gambia, Burkina Faso, and Benin) Cluster-randomized Controlled Trial.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Benin; Burkina Faso; Drug Combinati | 2019 |
Community-based Malaria Screening and Treatment for Pregnant Women Receiving Standard Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: A Multicenter (The Gambia, Burkina Faso, and Benin) Cluster-randomized Controlled Trial.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Benin; Burkina Faso; Drug Combinati | 2019 |
The impact of maternal antenatal treatment with two doses of azithromycin and monthly sulphadoxine-pyrimethamine on child weight, mid-upper arm circumference and head circumference: A randomized controlled trial.
Topics: Adult; Anti-Bacterial Agents; Antimalarials; Arm; Azithromycin; Birth Weight; Child; Child, Preschoo | 2019 |
Insights Into Circulating Cytokine Dynamics During Pregnancy in HIV-Infected Beninese Exposed to Plasmodium falciparum Malaria.
Topics: Adult; Antimalarials; Benin; Drug Combinations; Female; HIV Infections; Humans; Interleukin-10; Inte | 2015 |
Mother-to-child transmission of HIV-1: association with malaria prevention, anaemia and placental malaria.
Topics: Adult; Anemia; Anti-HIV Agents; Antimalarials; CD4 Lymphocyte Count; Drug Combinations; Female; HIV | 2008 |
A community effectiveness trial of strategies promoting intermittent preventive treatment with sulphadoxine-pyrimethamine in pregnant women in rural Burkina Faso.
Topics: Adolescent; Adult; Antimalarials; Burkina Faso; Chloroquine; Drug Combinations; Female; Health Promo | 2008 |
Placental malaria and low birth weight in pregnant women living in a rural area of Burkina Faso following the use of three preventive treatment regimens.
Topics: Adult; Animals; Antimalarials; Burkina Faso; Chemoprevention; Chloroquine; Drug Combinations; Female | 2009 |
HIV and placental infection modulate the appearance of drug-resistant Plasmodium falciparum in pregnant women who receive intermittent preventive treatment.
Topics: Adult; Alleles; Antimalarials; Chemoprevention; DNA, Protozoan; Drug Combinations; Drug Resistance; | 2011 |
[Pharmacovigilance and impact of intermittent preventive treatment with sulfadoxine-pyrimethamine in pregnant women in Sélingué, Mali].
Topics: Adolescent; Adult; Anemia; Antimalarials; Drug Administration Schedule; Drug Combinations; Endemic D | 2010 |
Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial.
Topics: Adolescent; Adult; Anemia; Antimalarials; Chemoprevention; Drug Combinations; Female; Humans; Infant | 2011 |
Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi.
Topics: Adolescent; Adult; Antimalarials; Drug Administration Schedule; Drug Combinations; Female; HIV Infec | 2006 |
Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women.
Topics: Adult; AIDS-Related Opportunistic Infections; Anemia; Antimalarials; Birth Weight; Double-Blind Meth | 2007 |
Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.
Topics: Adult; AIDS-Related Opportunistic Infections; Anemia; Antimalarials; Birth Weight; Double-Blind Meth | 2007 |
[Randomized clinical trial of two malaria prophylaxis regimens for pregnant women in Faladie, Mali].
Topics: Adult; Anemia; Antimalarials; Chloroquine; Drug Combinations; Endemic Diseases; Female; Humans; Infa | 2007 |
[Comparative impact of three malaria preventive regimens during pregnancy on maternal anemia due to malaria in Burkina Faso].
Topics: Adult; Anemia; Antimalarials; Burkina Faso; Chloroquine; Drug Therapy, Combination; Female; Humans; | 2008 |
Comparison of chloroquine, pyrimethamine and sulfadoxine, and chlorproguanil and dapsone as treatment for falciparum malaria in pregnant and non-pregnant women, Kakamega District, Kenya.
Topics: Adolescent; Adult; Animals; Antimalarials; Chloroquine; Dapsone; Drug Therapy, Combination; Female; | 1990 |
Lack of efficacy of pyrimethamine prophylaxis in pregnant Nigerian women.
Topics: Adolescent; Adult; Animals; Chloroquine; Drug Evaluation; Drug Resistance; Female; Follow-Up Studies | 1989 |
132 other studies available for pyrimethamine and Complications, Infectious Pregnancy
| Article | Year |
|---|---|
Malaria prophylaxis.
Topics: Antimalarials; Child; Chloroquine; Dapsone; Drug Combinations; Female; Humans; Malaria; Pregnancy; P | 1986 |
Susceptibility of Plasmodium falciparum in The Gambia to pyrimethamine, Maloprim and chloroquine.
Topics: Antimalarials; Child; Child, Preschool; Chloroquine; Dapsone; Dose-Response Relationship, Drug; Drug | 1985 |
"They Merely Prescribe and I Merely Swallow": Perceptions of Antenatal Pharmaceuticals and Nutritional Supplements Among Pregnant Women in Bamako, Mali.
Topics: Adult; Antimalarials; Antiretroviral Therapy, Highly Active; Drug Combinations; Female; Health Knowl | 2020 |
Antenatal visits are positively associated with uptake of tetanus toxoid and intermittent preventive treatment in pregnancy in Ivory Coast.
Topics: Adolescent; Adult; Antimalarials; Cote d'Ivoire; Drug Combinations; Female; Humans; Infant, Newborn; | 2019 |
Isolation and molecular characterization of Toxoplasma gondii from placental tissues of pregnant women who received toxoplasmosis treatment during an outbreak in southern Brazil.
Topics: Animals; Brazil; Coccidiostats; Disease Models, Animal; Disease Outbreaks; Female; Genotype; Humans; | 2020 |
Sulfadoxine-Pyrimethamine Exhibits Dose-Response Protection Against Adverse Birth Outcomes Related to Malaria and Sexually Transmitted and Reproductive Tract Infections.
Topics: Adult; Anti-Infective Agents; Chemoprevention; Drug Combinations; Female; Humans; Malaria; Pregnancy | 2017 |
High prevalence of dihydrofolate reductase gene mutations in Plasmodium falciparum parasites among pregnant women in Nigeria after reported use of sulfadoxine-pyrimethamine.
Topics: Adolescent; Adult; Animals; Antimalarials; Asymptomatic Diseases; Cross-Sectional Studies; Drug Comb | 2018 |
Congenital Toxoplasmosis in Tunisia: Prenatal and Neonatal Diagnosis and Postnatal Follow-up of 35 Cases.
Topics: Antiprotozoal Agents; Chorioretinitis; DNA, Protozoan; Drug Therapy, Combination; Female; Humans; Im | 2018 |
Improving health worker performance through text messaging: A mixed-methods evaluation of a pilot intervention designed to increase coverage of intermittent preventive treatment of malaria in pregnancy in West Nile, Uganda.
Topics: Antimalarials; Female; Guideline Adherence; Health Facilities; Health Personnel; Humans; Malaria; Pa | 2018 |
[Management of Toxoplasmic Seroconversion in the Third Trimester of Pregnancy in Tunisia].
Topics: Adult; Drug Combinations; Female; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical | 2018 |
Malaria control aimed at the entire population in KwaZulu-Natal negates the need for policies to prevent malaria in pregnancy.
Topics: Adolescent; Adult; Antimalarials; Communicable Disease Control; Drug Combinations; Female; Humans; I | 2013 |
High rates of parasite recrudescence following intermittent preventive treatment with sulphadoxine-pyrimethamine during pregnancy in Benin.
Topics: Adolescent; Adult; Antimalarials; Benin; Dihydropteroate Synthase; Drug Combinations; Female; Haplot | 2013 |
Prevention of malaria in pregnancy with intermittent preventive treatment and insecticide treated nets in Mali: a quantitative health systems effectiveness analysis.
Topics: Adult; Cross-Sectional Studies; Delivery of Health Care; Female; Humans; Insecticide-Treated Bednets | 2013 |
Perceptions of intermittent preventive treatment of malaria in pregnancy (IPTp) and barriers to adherence in Nasarawa and Cross River States in Nigeria.
Topics: Adolescent; Adult; Antimalarials; Chemoprevention; Cross-Sectional Studies; Drug Combinations; Femal | 2013 |
Toxoplasmosis and pregnancy.
Topics: Anti-Bacterial Agents; Antiprotozoal Agents; Female; Humans; Infant, Newborn; Infectious Disease Tra | 2014 |
Efficacy of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy, Mansa, Zambia.
Topics: Adolescent; Adult; Animals; Antimalarials; Drug Combinations; Drug Resistance; Drug Therapy, Combina | 2014 |
Submicroscopic malaria infection during pregnancy and the impact of intermittent preventive treatment.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Asymptomatic Diseases | 2014 |
Coverage and efficacy of intermittent preventive treatment with sulphadoxine pyrimethamine against malaria in pregnancy in Côte d'Ivoire five years after its implementation.
Topics: Adolescent; Adult; Antimalarials; Blood; Chemoprevention; Cote d'Ivoire; Cross-Sectional Studies; Dr | 2014 |
Uptake of intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria during pregnancy and pregnancy outcomes: a cross-sectional study in Geita district, North-Western Tanzania.
Topics: Adolescent; Adult; Antimalarials; Cross-Sectional Studies; Drug Combinations; Drug Therapy, Combinat | 2014 |
Evaluation of intermittent preventive treatment of malaria against group B Streptococcus colonization in pregnant women: a nested analysis of a randomized controlled clinical trial of sulfadoxine/pyrimethamine versus mefloquine.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antimalarials; Drug Combinations; Female; Gabon; Humans; M | 2015 |
Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in pregnant women in Yaoundé, Cameroon: emergence of highly resistant pfdhfr/pfdhps alleles.
Topics: Adult; Antimalarials; Cameroon; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female | 2015 |
Frequencies of dhfr/dhps multiple mutations and Plasmodium falciparum submicroscopic gametocyte carriage in Gabonese pregnant women following IPTp-SP implementation.
Topics: Antimalarials; Carrier State; Chemoprevention; Dihydropteroate Synthase; DNA, Protozoan; Drug Combin | 2015 |
Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness of Intermittent Preventive Therapy for Malaria in Pregnancy at Clearing Infections and Preventing Low Birth Weight.
Topics: Adult; Africa South of the Sahara; Amino Acid Substitution; Antimalarials; Dihydropteroate Synthase; | 2016 |
Assessment of the usage and effectiveness of intermittent preventive treatment and insecticide-treated nets on the indicators of malaria among pregnant women attending antenatal care in the Buea Health District, Cameroon.
Topics: Adolescent; Adult; Anemia; Antimalarials; Blood; Cameroon; Chemoprevention; Cross-Sectional Studies; | 2016 |
Assessing supply-side barriers to uptake of intermittent preventive treatment for malaria in pregnancy: a qualitative study and document and record review in two regions of Uganda.
Topics: Antimalarials; Drug Combinations; Female; Health Services Accessibility; Humans; Interviews as Topic | 2016 |
The challenge of using intermittent preventive therapy with sulfadoxine/pyrimethamine among pregnant women in Uganda.
Topics: Adolescent; Adult; Antimalarials; Drug Combinations; Female; Health Knowledge, Attitudes, Practice; | 2016 |
Scaling-up the use of sulfadoxine-pyrimethamine for the preventive treatment of malaria in pregnancy: results and lessons on scalability, costs and programme impact from three local government areas in Sokoto State, Nigeria.
Topics: Adolescent; Adult; Antimalarials; Drug Combinations; Female; Health Care Costs; Humans; Infant, Newb | 2016 |
Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V.
Topics: Adult; Antimalarials; Child; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resis | 2016 |
Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V.
Topics: Adult; Antimalarials; Child; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resis | 2016 |
Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V.
Topics: Adult; Antimalarials; Child; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resis | 2016 |
Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V.
Topics: Adult; Antimalarials; Child; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resis | 2016 |
Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V.
Topics: Adult; Antimalarials; Child; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resis | 2016 |
Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V.
Topics: Adult; Antimalarials; Child; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resis | 2016 |
Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V.
Topics: Adult; Antimalarials; Child; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resis | 2016 |
Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V.
Topics: Adult; Antimalarials; Child; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resis | 2016 |
Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V.
Topics: Adult; Antimalarials; Child; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resis | 2016 |
Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine: More Than Just an Antimalarial?
Topics: Antimalarials; Drug Combinations; Female; HIV Infections; Humans; Malaria; Pregnancy; Pregnancy Comp | 2017 |
Antimalarial treatment patterns among pregnant women attending antenatal care clinics in south east Nigeria and the future implications.
Topics: Adult; Ambulatory Care Facilities; Antimalarials; Drug Combinations; Female; Humans; Malaria; Nigeri | 2016 |
The challenges of diagnosis and treatment of malaria in pregnancy in low resource settings.
Topics: Antimalarials; Developing Countries; Drug Combinations; Female; Health Resources; Humans; Malaria; P | 2008 |
High prevalence of sulfadoxine/pyrimethamine-resistant alleles of Plasmodium falciparum isolates in pregnant women at the time of introduction of intermittent preventive treatment with sulfadoxine/pyrimethamine in Gabon.
Topics: Alleles; Amino Acid Substitution; Animals; Antimalarials; Blood; Dihydropteroate Synthase; DNA Restr | 2010 |
Intermittent preventive treatment of malaria in pregnancy (IPTp): do frequent antenatal care visits ensure access and compliance to IPTp in Ugandan rural communities?
Topics: Adolescent; Adult; Antimalarials; Child; Drug Combinations; Female; Health Services Accessibility; H | 2010 |
Trends in pregnancy outcomes in Malawian adolescents receiving antimalarial and hematinic supplements.
Topics: Adolescent; Adult; Anemia; Antimalarials; Cross-Sectional Studies; Delivery, Obstetric; Drug Combina | 2010 |
Long-term outcome of children with congenital toxoplasmosis.
Topics: Age Factors; Child; Child Development; Child, Preschool; Chorioretinitis; Cohort Studies; Drug Combi | 2010 |
Anti-bacterial activity of intermittent preventive treatment of malaria in pregnancy: comparative in vitro study of sulphadoxine-pyrimethamine, mefloquine, and azithromycin.
Topics: Anti-Bacterial Agents; Antimalarials; Azithromycin; Bacterial Infections; Drug Combinations; Female; | 2010 |
Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi.
Topics: Adolescent; Adult; Anemia; Antimalarials; Chemoprevention; Cross-Sectional Studies; Drug Combination | 2011 |
Knowledge of malaria and preventive measures among pregnant women attending antenatal clinics in a rural local government area in Southwestern Nigeria.
Topics: Adolescent; Adult; Antimalarials; Chemoprevention; Cross-Sectional Studies; Drug Combinations; Femal | 2011 |
Field evaluation of the intermittent preventive treatment of malaria during pregnancy (IPTp) in Benin: evolution of the coverage rate since its implementation.
Topics: Adolescent; Adult; Antimalarials; Benin; Chemoprevention; Child; Drug Combinations; Drug Utilization | 2011 |
Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance.
Topics: Adult; Antimalarials; Chemoprevention; Cross-Sectional Studies; Drug Combinations; Drug Resistance; | 2011 |
The use of intermittent preventive treatment with sulfadoxine-pyrimethamine for preventing malaria in pregnant women.
Topics: Antimalarials; Chemoprevention; Drug Combinations; Drug Resistance; Female; Humans; Malaria; Male; P | 2011 |
[Comparison of efficacy of chloroquine versus sulfadoxine-pyrimethamine in malaria prevention in pregnant women in the Toamasina region (Madagascar)].
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Drug Combinations; Endemic Diseases; Female; Humans; | 2011 |
Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya.
Topics: Adult; Antimalarials; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; | 2012 |
Validity of self-reported use of sulphadoxine-pyrimethamine intermittent presumptive treatment during pregnancy (IPTp): a cross-sectional study.
Topics: Adolescent; Adult; Antimalarials; Blood; Chemoprevention; Chromatography, High Pressure Liquid; Cros | 2012 |
[TERATOGENIC ACTION OF DRUGS IN THE PREGNANT WOMAN].
Topics: Abnormalities, Drug-Induced; Antineoplastic Agents; Avitaminosis; Chlorpromazine; Cortisone; Female; | 1963 |
CONTROLLED TRIAL OF PYRIMETHAMINE IN PREGNANT WOMEN IN AN AFRICAN VILLAGE.
Topics: Birth Weight; Chloroquine; Female; Humans; Infant; Infant Mortality; Lactose; Malaria; Nigeria; Preg | 1964 |
[ACQUIRED TOXOPLASMOSIS].
Topics: Communicable Disease Control; Communicable Diseases; Female; Humans; Pregnancy; Pregnancy Complicati | 1963 |
[PREVENTION AND THERAPY OF CONNATAL TOXOPLASMOSIS].
Topics: Communicable Diseases; Epidemiology; Female; Humans; Infant; Infant, Newborn; Pregnancy; Pregnancy C | 1963 |
[ON THE EPIDEMIOLOGY OF TOXOPLASMOSIS].
Topics: Animals; Communicable Diseases; Eggs; Epidemiology; Female; Humans; Infant; Infant, Newborn; Insect | 1964 |
GLANDULAR TOXOPLASMOSIS. OCCURRENCE OF THE DISEASE IN FINLAND.
Topics: Biopsy; Diagnosis, Differential; Epidemiology; Female; Finland; Hodgkin Disease; Humans; Lymph Node | 1964 |
[TOXOPLASMOSIS IN ADULTS].
Topics: Adult; Diagnosis; Encephalomyelitis; Female; Humans; Meningoencephalitis; Pregnancy; Pregnancy Compl | 1965 |
THE TREATMENT OF GLANDULAR TOXOPLASMOSIS.
Topics: Child; Choroiditis; Drug Therapy; Female; Folic Acid; Humans; Lung Diseases; Lymphadenitis; Meningit | 1965 |
[THE SIGNIFICANCE OF TOXOPLASMOSIS FOR OBSTETRICS].
Topics: Communicable Diseases; Diagnosis; Drug Therapy; Female; Fetus; Humans; Obstetrics; Pregnancy; Pregna | 1965 |
Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management.
Topics: Adult; Age Distribution; Antiprotozoal Agents; Chorioretinitis; Drug Therapy, Combination; Female; G | 2004 |
Effectiveness of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in western Kenya: a hospital-based study.
Topics: Adult; AIDS-Related Opportunistic Infections; Antimalarials; Birth Weight; Cohort Studies; Drug Admi | 2004 |
Reliability of immunoglobulin G antitoxoplasma avidity test and effects of treatment on avidity indexes of infants and pregnant women.
Topics: Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Humans; Immunoenzyme Techniques; | 2004 |
Congenital toxoplasmosis from an HIV-infected woman as a result of reactivation.
Topics: Adult; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Female; Fetal Blood; HIV Infections; Hu | 2006 |
[Postnatal follow-up of infants born to mothers with certain Toxoplasma gondii infection: evaluation of prenatal management].
Topics: Adolescent; Adult; Amniocentesis; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Chorioretini | 2005 |
Reaching the Abuja target for intermittent preventive treatment of malaria in pregnancy in African women: a review of progress and operational challenges.
Topics: Africa South of the Sahara; Antimalarials; Attitude to Health; Delivery of Health Care, Integrated; | 2006 |
Effect of haematinic supplementation and malaria prevention on maternal anaemia and malaria in western Kenya.
Topics: Adult; Anemia; Antimalarials; Drug Combinations; Drug Therapy, Combination; Female; Folic Acid; Hema | 2007 |
Intermittent preventive treatment of malaria in pregnancy: the effect of new delivery approaches on access and compliance rates in Uganda.
Topics: Adolescent; Adult; Age Distribution; Antimalarials; Child; Delivery of Health Care; Drug Combination | 2007 |
A community-based delivery system of intermittent preventive treatment of malaria in pregnancy and its effect on use of essential maternity care at health units in Uganda.
Topics: Adolescent; Adult; Antimalarials; Child; Drug Combinations; Female; Humans; Malaria; Patient Complia | 2007 |
Pharmacologic advances in the global control and treatment of malaria: combination therapy and resistance.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Dapsone; Drug Design; | 2007 |
Intermittent preventive therapy with sulfadoxine-pyrimethamine during pregnancy: seeking information on optimal dosing frequency.
Topics: Adult; AIDS-Related Opportunistic Infections; Antimalarials; Disease Susceptibility; Drug Administra | 2007 |
Intermittent preventive treatment of malaria during pregnancy in central Mozambique.
Topics: Antimalarials; Drug Administration Schedule; Drug Combinations; Female; Health Policy; Humans; Malar | 2007 |
Effect of a community-based delivery of intermittent preventive treatment of malaria in pregnancy on treatment seeking for malaria at health units in Uganda.
Topics: Adolescent; Adult; Antimalarials; Community Health Services; Drug Administration Schedule; Drug Comb | 2008 |
[On the treatment of toxoplasmosis with daraprin].
Topics: Adult; Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Toxoplasmosis | 1966 |
Pyrimethamine combinations in pregnancy.
Topics: Abnormalities, Drug-Induced; Female; Humans; Malaria; Pregnancy; Pregnancy Complications, Infectious | 1983 |
Pyrimethamine in pregnancy.
Topics: Abnormalities, Drug-Induced; Female; Humans; Malaria; Pregnancy; Pregnancy Complications, Infectious | 1983 |
Treatment of chloroquine-resistant malaria during pregnancy.
Topics: Adult; Chloroquine; Drug Therapy, Combination; Female; Humans; Malaria; Plasmodium falciparum; Pregn | 1983 |
Management of Plasmodium falciparum malaria.
Topics: Amodiaquine; Anemia; Antimalarials; Brain Diseases; Chloroquine; Drug Resistance; Female; Humans; Hy | 1984 |
[Toxoplasmosis and pregnancy. Prevention, early detection and therapy].
Topics: Austria; Drug Therapy, Combination; Female; Humans; Mass Screening; Pregnancy; Pregnancy Complicatio | 1983 |
[Congenital toxoplasmosis; observations on the recommendation of the Public Health Council].
Topics: Female; Humans; Infant, Newborn; Leucomycins; Pregnancy; Pregnancy Complications, Infectious; Pyrime | 1984 |
Toxoplasmosis.
Topics: Cooking; Feces; Female; Food Contamination; Humans; Infant, Newborn; Infant, Newborn, Diseases; Inse | 1980 |
[Toxoplasmosis].
Topics: Adult; Animals; Antibodies; Antimalarials; Drug Therapy, Combination; Female; Humans; Immunologic Te | 1980 |
A pyrimethamine-chloroquine combination for malaria prophylaxis during pregnancy.
Topics: Abnormalities, Drug-Induced; Chloroquine; Drug Combinations; Female; Fetus; Humans; Malaria; Pregnan | 1982 |
[Toxoplasmosis and pregnancy].
Topics: Adult; Arsenicals; Female; Humans; Leucomycins; Pregnancy; Pregnancy Complications, Infectious; Pyri | 1982 |
[Congenital toxoplasmosis in two newborn infants (author's transl)].
Topics: Adult; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Male; Pr | 1981 |
The management and treatment of malaria (a personal view).
Topics: Chloroquine; Female; Humans; Malaria; Male; Pregnancy; Pregnancy Complications, Infectious; Proguani | 1980 |
[Treatment of toxoplasmosis in obstetrics and gynecology].
Topics: Antiprotozoal Agents; Aspirin; Drug Therapy, Combination; Female; Humans; Leucomycins; Pregnancy; Pr | 1981 |
The effect of malarial chemoprophylaxis on immunoglobulin levels of pregnant Nigerian women and the newborn.
Topics: Chloroquine; Female; Fetal Blood; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immu | 1980 |
[Medullary aplasia during treatment for congenital toxoplasmosis in a twin pregnancy].
Topics: Adult; Anemia, Aplastic; Anemia, Sideroblastic; Cordocentesis; Female; Folic Acid; Folic Acid Defici | 1993 |
Increased prevalence of malaria in HIV-infected pregnant women and its implications for malaria control.
Topics: Adult; AIDS-Related Opportunistic Infections; Antimalarials; Cross-Sectional Studies; Drug Combinati | 1999 |
Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Cohort Studies; Female; Fetal Blood; Fetal Dis | 2001 |
[Lymphadenitis caused by toxoplasmosis during gravidity -- an aetiological factor in congenital damage to the child (author's transl)].
Topics: Anti-Bacterial Agents; Female; Humans; Hydrocephalus; Infant, Newborn; Lymphadenitis; Male; Pregnanc | 1979 |
[The significance of toxoplasmosis in pregnancy].
Topics: Abortion, Spontaneous; Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectio | 1977 |
[Treatment of toxoplasmosis during pregnancy].
Topics: Drug Therapy, Combination; Female; Humans; Leucovorin; Pregnancy; Pregnancy Complications, Infectiou | 1976 |
The clinical spectrum of toxoplasmosis in the adult.
Topics: Adult; Female; History of Medicine; Humans; Male; Prednisone; Pregnancy; Pregnancy Complications, In | 1975 |
Treatment and results of chronic toxoplasmosis. Analysis of 33 cases.
Topics: Abortion, Spontaneous; Female; Fetal Death; Humans; Obstetric Labor, Premature; Pregnancy; Pregnancy | 1992 |
[Prevention of congenital toxoplasmosis].
Topics: Adult; Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Prenatal Dia | 1990 |
Pancytopenia in a patient given pyrimethamine and sulphamethoxidiazine during pregnancy.
Topics: Adult; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Male; Pancytopenia; Pregnancy; Pr | 1990 |
Treatment of congenital toxoplasmosis during pregnancy.
Topics: Female; Fetal Diseases; Humans; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; P | 1990 |
Congenital toxoplasmosis occurring in infants perinatally infected with human immunodeficiency virus 1.
Topics: Acquired Immunodeficiency Syndrome; Animals; Central Nervous System Diseases; Family Health; Female; | 1990 |
Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment.
Topics: Female; Follow-Up Studies; Humans; Infant, Newborn; Predictive Value of Tests; Pregnancy; Pregnancy | 1989 |
New perspectives in the chemoprophylaxis of toxoplasmosis.
Topics: Chorioretinitis; Drug Combinations; Female; Fetal Diseases; Humans; Immune Tolerance; Infant, Newbor | 1989 |
Multiple drug resistant Plasmodium falciparum malaria in a pregnant indigenous Zambian woman.
Topics: Adult; Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Erythro | 1988 |
[Clinical aspects of Toxoplasma primary infection in pregnancy].
Topics: Animals; Antibodies, Protozoan; Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Pyri | 1988 |
[Toxoplasmosis in Mendoza and general findings].
Topics: Adolescent; Adult; Age Factors; Animals; Argentina; Complement Fixation Tests; Female; Hemagglutinat | 1968 |
[Toxoplasmosis according to materials of the Ioshkar-Olinsk maternity home].
Topics: Adult; Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Russia; Toxopl | 1968 |
Toxoplasmosis in pregnancy and its transmission to the fetus.
Topics: Adolescent; Adult; Female; Gestational Age; Humans; Infant; Infant, Newborn; Leucomycins; Maternal-F | 1974 |
The management of toxoplasmosis in pregnancy.
Topics: Abortion, Spontaneous; Abortion, Therapeutic; Female; Humans; Infant; Infant, Newborn; Leucovorin; P | 1974 |
[Considerations on some cases of repeated abortions probabily due to Toxoplasma gondii (author's transl)].
Topics: Abortion, Habitual; Adult; Antibody Formation; Drug Therapy, Combination; Female; Folic Acid; Humans | 1972 |
Latent toxoplasmosis and pregnancy.
Topics: Abortion, Habitual; Antibodies; Female; Fetal Death; Glucose Tolerance Test; Humans; Obstetric Labor | 1973 |
[Signification of laboratory methods in the diagnosis, treatment and prevention of toxoplasmosis in gynecology and obstetrics].
Topics: Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Toxoplasmosis | 1973 |
Symptoms, transmission, prevention and treatment of toxoplasmosis.
Topics: Adult; Animals; Cat Diseases; Cats; Child; Dogs; Female; Humans; Infant; Infant, Newborn; Lymph Node | 1973 |
[Regular supervision of pregnant women for the prevention of congenital toxoplasmosis].
Topics: Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Pyri | 1973 |
Toxoplasmosis.
Topics: BCG Vaccine; Female; Humans; Infant, Newborn; Leucomycins; Pregnancy; Pregnancy Complications, Infec | 1973 |
Congenital toxoplasmosis. A prospective study of 378 pregnancies.
Topics: Antibodies; Female; Humans; Infant, Newborn; Leucomycins; Methods; Paris; Placenta; Pregnancy; Pregn | 1974 |
[Experiences in the care for pregnant women with pregnancies endangered by latent toxoplasmosis].
Topics: Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Toxoplasmosis | 1974 |
[Contribution to the diagnostics and treatment of toxoplasmosis (author's transl)].
Topics: Anti-Bacterial Agents; Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine | 1974 |
[Diagnostics and treatment of toxoplasmosis (author's transl)].
Topics: Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfonamides; Toxopla | 1974 |
[Justification and methods of preventive treatment in chronic toxoplasmosis during pregnancy (author's transl)].
Topics: Anti-Bacterial Agents; Chronic Disease; Female; Humans; Pregnancy; Pregnancy Complications, Infectio | 1974 |
[Our approach to prevention and treatment of toxoplasmosis (author's transl)].
Topics: Anti-Bacterial Agents; Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine | 1974 |
[Teratogenicity of daraprim (pyrimethamine) in man].
Topics: Abnormalities, Drug-Induced; Adult; Female; Gestational Age; Humans; Pregnancy; Pregnancy Complicati | 1972 |
[Toxoplasmosis and pathological pregnancy].
Topics: Adult; Female; Humans; Leucomycins; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; S | 1972 |
Toxoplasmosis. With comments on risk of infection from cats.
Topics: Animals; Cat Diseases; Cats; Feces; Female; Food Contamination; Humans; Male; Meat; Pregnancy; Pregn | 1972 |
[Prophylactic treatment of pregnant women showing positive reactions to toxoplasmosis].
Topics: Evaluation Studies as Topic; Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Pyrimet | 1972 |
[Treatment of toxoplasmosis in women].
Topics: Female; Humans; Leucomycins; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfadim | 1972 |
[Ocular toxoplasmosis].
Topics: Diagnosis, Differential; Eye; Female; Humans; Leucovorin; Prednisone; Pregnancy; Pregnancy Complicat | 1968 |
[Stages in the prophylaxis of toxoplasmosis].
Topics: Adult; Bone Marrow; Bone Marrow Diseases; Female; Humans; Leucovorin; Pregnancy; Pregnancy Complicat | 1970 |
[The effect of treatment of the activity of antibodies against T. gondii in humans].
Topics: Antibodies; Antibody Formation; Complement Fixation Tests; Female; Humans; Pregnancy; Pregnancy Comp | 1969 |
Toxoplasmosis.
Topics: Communicable Diseases; Complement Fixation Tests; Female; Hemagglutination Tests; Humans; Infant, Ne | 1970 |
[Panmyelopathy following use of Daraprim in therapy of toxoplasmosis].
Topics: Adult; Bone Marrow Diseases; Female; Hematopoiesis; Humans; Pregnancy; Pregnancy Complications, Infe | 1970 |
[Epidemiology, clinical aspects and therapy of toxoplasmosis].
Topics: Administration, Oral; Adult; Animals; Child; Complement Fixation Tests; Diagnosis, Differential; Fem | 1970 |
[Relation of the activity of serum transaminases and hepatic tests on the positivity of serologic reactions to toxoplasmosis].
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Female; Humans; Liver Function Tests; Preg | 1971 |
[The state and psychophysical development of children born to mothers receiving antitoxoplasmosis treatment].
Topics: Adult; Congenital Abnormalities; Female; Fetal Death; Growth; Humans; Infant; Infant, Newborn; Infan | 1967 |
[Various data on the treatment of toxoplasmosis with chloridin].
Topics: Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfamethazine; Toxop | 1968 |
[Studies on the teratogenic effect of drugs in the treatment of toxoplasmosis during pregnancy].
Topics: Abnormalities, Drug-Induced; Anti-Bacterial Agents; Female; Humans; Pregnancy; Pregnancy Complicatio | 1965 |
[Life-endangering hemorrhage after the treatment of toxoplasmosis with Daraprim and Supracid].
Topics: Adult; Female; Hemorrhagic Disorders; Humans; Pregnancy; Pregnancy Complications, Infectious; Pyrime | 1966 |
[Preventive treatment of latent toxoplasmosis in pregnant patients].
Topics: Chlortetracycline; Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; | 1966 |
[Toxoplasmosis and pregnancy. Delivery of a healthy child despite maternal lymph node toxoplasmosis in early pregnancy].
Topics: Adult; Female; Humans; Infant, Newborn; Lymph Nodes; Maternal-Fetal Exchange; Pregnancy; Pregnancy C | 1966 |
[The effect of chloridin on the blood of pregnant women].
Topics: Adult; Blood Cell Count; Blood Cells; Blood Sedimentation; Female; Hemoglobinometry; Humans; Pregnan | 1966 |